Literature DB >> 3675823

Open field and elevated plus-maze: a behavioural comparison between spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats and the effects of chlordiazepoxide.

C Gentsch1, M Lichtsteiner, H Feer.   

Abstract

An interstrain comparison was conducted between male spontaneously hypertensive rats and Wistar-Kyoto rats, in both the open field and the elevated plus-maze. Wistar-Kyoto rats, as compared to the hypertensive animals, showed, beside an attenuated locomotor activity in both test situations, a higher reaction to aversive environments (less entries into the central area of the open field and less visits to the open arms of the elevated plus-maze). Chlordiazepoxide, as potent anxiolytic, increased (1) general activity, (2) the frequency of entries into the open area of the open field, and (3) the number of visits to the open arms of the elevated plus-maze in both rat strains.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3675823     DOI: 10.1016/0166-4328(87)90003-9

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  23 in total

1.  Regional brain variations of cytochrome oxidase activity in spontaneously hypertensive mice.

Authors:  C Strazielle; R Lalonde; S Thifault; P Hamet
Journal:  Exp Brain Res       Date:  2004-03-06       Impact factor: 1.972

2.  Genetic and environmental influences on reactive and spontaneous locomotor activities in rats.

Authors:  C Gentsch; M Lichtsteiner; H Feer
Journal:  Experientia       Date:  1991-10-15

3.  Long-Term Treatment with Losartan Attenuates Seizure Activity and Neuronal Damage Without Affecting Behavioral Changes in a Model of Co-morbid Hypertension and Epilepsy.

Authors:  Jana D Tchekalarova; Natasha Ivanova; Dimitrina Atanasova; Daniela M Pechlivanova; Nikolai Lazarov; Lidia Kortenska; Rumiana Mitreva; Valentin Lozanov; Alexander Stoynev
Journal:  Cell Mol Neurobiol       Date:  2015-10-13       Impact factor: 5.046

4.  Effects on enantiomeric drug disposition and open-field behavior after chronic treatment with venlafaxine in the P-glycoprotein knockout mice model.

Authors:  Louise Karlsson; Christoph Hiemke; Björn Carlsson; Martin Josefsson; Johan Ahlner; Finn Bengtsson; Ulrich Schmitt; Fredrik C Kugelberg
Journal:  Psychopharmacology (Berl)       Date:  2010-12-30       Impact factor: 4.530

5.  Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats.

Authors:  Maria Sabrina Spano; Liana Fattore; Francesca Cadeddu; Walter Fratta; Paola Fadda
Journal:  Psychopharmacology (Berl)       Date:  2012-08-19       Impact factor: 4.530

6.  Maternal separation with early weaning: a rodent model providing novel insights into neglect associated developmental deficits.

Authors:  Becky C Carlyle; Alvaro Duque; Robert R Kitchen; Kelly A Bordner; Daniel Coman; Eliza Doolittle; Xenophonios Papademetris; Fahmeed Hyder; Jane R Taylor; Arthur A Simen
Journal:  Dev Psychopathol       Date:  2012-11

7.  Neuroleptic drugs revert the contextual fear conditioning deficit presented by spontaneously hypertensive rats: a potential animal model of emotional context processing in schizophrenia?

Authors:  Mariana Bendlin Calzavara; Wladimir Agostini Medrano; Raquel Levin; Sonia Regina Kameda; Monica Levy Andersen; Sergio Tufik; Regina Helena Silva; Roberto Frussa-Filho; Vanessa Costhek Abílio
Journal:  Schizophr Bull       Date:  2008-02-16       Impact factor: 9.306

8.  Dexmedetomidine synergism with midazolam in the elevated plus-maze test in rats.

Authors:  M Salonen; E S Onaivi; M Maze
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

9.  Wall following in Xenopus laevis is barrier-driven.

Authors:  Sara Hänzi; Hans Straka
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2017-11-08       Impact factor: 1.836

Review 10.  Genetic and environmental influences on behavioral and neurochemical aspects of emotionality in rats.

Authors:  C Gentsch; M Lichtsteiner; H Feer
Journal:  Experientia       Date:  1988-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.